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We will report the current situation of tuberculosis glob-
ally and in Brazil, the need for new strategies towards
tuberculosis control, focusing on new diagnostic technolo-
gies. Critical comments are given on the state of the art
regarding the evaluation of new health technologies,
degree of scientific evidence needed, evaluation of clinical
impact, cost-effectiveness of incorporation into the health
system and the social impact.
Currently, the given pragmatic approach indicates that it
is not appropriate to conduct an investigation on the incor-
poration of new technologies only in a “purely experimen-
tal” manner in clinical research centers. Research and
practice clinical processes become intertwined and the
main outcomes to be considered are the patient’s health
and actions creating a more effective health system in
which the new technology will be incorporated. In this new
scenario, it is essential that the academic biomedical areas
reformulate their undergraduate curricula to include
courses that address the development of new technologies,
including the assessment of clinical impact, and economic
and social incorporation of these new technologies into the
current health system that will influence the future practice
of their graduate students. In parallel, only through colla-
borative activities between academics, health service provi-
ders (public or private), producers of raw materials,
laboratories and representatives of civil society will it be
possible to conduct such studies under routine conditions
in demonstration areas to enable an analysis appropriate to
the relevance of the incorporation of new technologies in
the country.
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